Ulicrit 1,000,000 IU Injection: High Potency Vitamin Supplement

Description:

• Contains Ulinastatin, also known as a urinary trypsin inhibitor (UTI).
• Used for its anti-inflammatory and immunomodulatory effects.
• Initially isolated from human urine.

Uses:

• Treatment of acute pancreatitis.
• Management of sepsis (severe bacterial infection).
• Treatment of acute respiratory distress syndrome (ARDS).

Mechanism of Action:

• Inhibits proteolytic enzymes such as trypsin and elastase.
• Reduces activation of inflammatory pathways.
• Modulates the immune response.

Administration:

• Administered intravenously under medical supervision.
• Dosage and administration guidelines determined by healthcare professional.

Contraindications:

• Contraindicated in patients with hypersensitivity to the drug or its components.
• Limited research on safety and efficacy in pediatric patients or the elderly.
• Caution advised in pregnancy and breastfeeding.

Interactions:

• Inform doctor about all medications, including prescription, over-the-counter, nutritional supplements, and herbal products.
• Certain medications may interact with Ulicrit 1,00,000 IU Injection.

Storage:

• Store at temperature 2°C - 8°C.
• Keep away from moisture, heat, and light.
• Do not freeze.
• Keep away from children and pets.

Safety Advice:

• Pregnancy: consult healthcare provider.
• Breastfeeding: consult healthcare provider.
• Lung conditions: consult healthcare provider.
• Liver conditions: consult healthcare provider.
• Avoid alcohol: may cause increased drowsiness or impaired cognitive function.
• Driving: may cause dizziness, lightheadedness, blurred vision, or transient changes in heart rhythm.

Side Effects:

• Serious: severe allergic reactions, anaphylaxis, signs of infection, changes in kidney function, abnormal bleeding or bruising, liver problems, neurological symptoms.
• Common: nausea, vomiting, diarrhea, skin rashes or itching, headache, dizziness, fever or chills, injection site reactions.

FAQs:

1. Common side effects: nausea, vomiting, diarrhea, skin rashes, headache, and injection site reactions.
2. Use in children: safety and efficacy not fully established.
3. Missed dose: contact healthcare provider for guidance.
4. Special monitoring: regular monitoring of kidney and liver function, blood cell counts, and overall clinical status.
5. Stopping treatment: complete full course as prescribed by healthcare provider.
6. Duration of treatment: varies depending on medical condition, patient's response, and healthcare provider's assessment.
7. Onset of action: varies depending on individual and medical condition.

Fact Box:

• Molecule name: Ulinastatin
• Therapeutic class: Urinary Trypsin Inhibitor
• Pharmacological class: Protease Inhibitors
• Indications: Acute pancreatitis, Sepsis, Acute respiratory distress syndrome

Tags: medical-injection, vitamin-injection, ulicrit-injection, health-supplement, pharmaceutical-product